Compare · CF vs NITO
CF vs NITO
Side-by-side comparison of CF Industries Holdings Inc. (CF) and N2OFF Inc. (NITO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CF and NITO operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- CF carries a market cap of $17.91B.
- CF has hit the wire 3 times in the past 4 weeks while NITO has been quiet.
- CF has more recent analyst coverage (25 ratings vs 0 for NITO).
- Company
- CF Industries Holdings Inc.
- N2OFF Inc.
- Price
- $116.62+2.77%
- $1.25+32.98%
- Market cap
- $17.91B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2005
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 0
CF Industries Holdings Inc.
CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for clean energy, fertilizer, emissions abatement, and other industrial applications worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
Latest CF
- EVP and CFO Scribner Andrew was granted 6,464 shares (SEC Form 4)
- SEC Form 3 filed by new insider Scribner Andrew
- SEC Form 144 filed by CF Industries Holdings Inc.
- SEC Form 10-Q filed by CF Industries Holdings Inc.
- CF Industries Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- CF Industries Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- CF Industries Holdings, Inc. Reports First Quarter 2026 Net Earnings of $615 Million, Adjusted EBITDA of $983 Million
- CF Industries Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Andrew T. Scribner Elected Executive Vice President and Chief Financial Officer of CF Industries Holdings, Inc.
- CF Industries Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest NITO
- SEC Form PRE 14A filed by N2OFF Inc.
- N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- N2OFF Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
- MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
- Chief Executive Officer Palach David was granted 100,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Controller Zakai Shlomo was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Director Weiss Amitay was granted 116,286 units of Restricted Shares of Common Stock (SEC Form 4)
- Chief Financial Officer Barda Lital was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- In Spaceflight Conditions: N2OFF's MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions